In addition, studies in yeast point toward a role of the Target of Rapamycin (TOR) complex 2 (TORC2), which is closely related to obesity and metabolic control, in regulating SPT-dependent ceramide formation and CerS phosphorylation [227, 228]. Here, AGXT is linked to obesity disorder.